8 research outputs found
Altered plasma proteome during an early phase of an experimental model of peritonitis-induced sepsis
Supplementary Material for: Unravelling Pathophysiology of Crystalline Nephropathy in Ceftriaxone-Associated Acute Kidney Injury: A Cellular Proteomic Approach
<b><i>Background:</i></b> Previous studies showed that ceftriaxone can cause acute kidney injury (AKI) in the pediatric population. This study proposed a cellular model of crystalline nephropathy in ceftriaxone-associated AKI and explored the related pathophysiology by using a proteomic approach. <b><i>Methods:</i></b> Ceftriaxone was crystallized with calcium in artificial urine. Madin-Darby Canine Kidney (MDCK) cells, a model of distal renal tubular cell, were cultured in the absence (untreated control) or presence of ceftriaxone crystals for 48-h (<i>n</i> = 5 each). MDCK cells were harvested and subsequently analyzed by proteomic analysis. Protein bioinformatics (i.e., STRING and Reactome) was used to predict functional alterations, and subsequently validated by Western blotting and cellular studies. <i>p <</i> 0.05 was considered statistically significant. <b><i>Results:</i></b> Phase-contrast microscopy showed increased intracellular vesiculation and cell enlargement as a result of ceftriaxone crystal exposure. Proteome analysis revealed a total of 20 altered proteins (14 increased, 5 decreased and 1 absent) in ceftriaxone crystal-treated MDCK cells as compared to untreated cells (<i>p</i> < 0.05). Protein bioinformatics and validation studies supported heat stress response mediated by heat shock protein 70 (Hsp70) and downregulation of annexin A1 as the proposed pathophysiology of crystalline nephropathy in ceftriaxone-associated AKI, in which impaired proliferation and wound healing of crystal-induced distal tubular cells were outcomes. <b><i>Conclusions:</i></b> This study, for the first time, used the in vitro model of crystalline nephropathy to investigate the underlying pathophysiology of ceftriaxone-associated AKI, which should be investigated in vivo for potential clinical benefits in the future
Chromosome-centric Human Proteome Project (C-HPP): Chromosome 12
Following an official announcement of the Chromosome-centric Human Proteome Project (C-HPP), the Chromosome 12 (Ch12) Consortium has been established by five representative teams from five Asian countries including Thailand (Siriraj Hospital, Mahidol University), Singapore (National University of Singapore), Taiwan (Academia Sinica), Hong Kong (The Chinese University of Hong Kong), and India (Institute of Bioinformatics). We have worked closely together to extensively and systematically analyze all missing and known proteins encoded by Ch12 for their tissue/cellular/subcellular localizations. The target organs/tissues/cells include kidney, brain, gastrointestinal tissues, blood/immune cells, and stem cells. In the later phase, post-translational modifications and functional significance of Ch12-encoded proteins as well as their associations with human diseases (i.e., immune diseases, metabolic disorders, and cancers) will be defined. We have collaborated with other chromosome teams, Human Kidney and Urine Proteome Project (HKUPP), AOHUPO Membrane Proteomics Initiative, and other existing HUPO initiatives in the Biology/Disease-Based Human Proteome Project (B/D-HPP) to delineate functional roles and medical implications of Ch12-encoded proteins. The data set to be obtained from this multicountry consortium will be an important piece of the jigsaw puzzle to fulfill the missions and goals of the C-HPP and the global Human Proteome Project (HPP)
Alpha-enolase on apical surface of renal tubular epithelial cells serves as a calcium oxalate crystal receptor
Calcium oxalate crystals increased enolase-1 secretion from renal tubular cells that subsequently enhanced crystal and monocyte invasion through renal interstitium
Chromosome-centric Human Proteome Project (C-HPP): Chromosome 12
Following an official announcement
of the Chromosome-centric Human
Proteome Project (C-HPP), the Chromosome 12 (Ch12) Consortium has
been established by five representative teams from five Asian countries
including Thailand (Siriraj Hospital, Mahidol University), Singapore
(National University of Singapore), Taiwan (Academia Sinica), Hong
Kong (The Chinese University of Hong Kong), and India (Institute of
Bioinformatics). We have worked closely together to extensively and
systematically analyze all missing and known proteins encoded by Ch12
for their tissue/cellular/subcellular localizations. The target organs/tissues/cells
include kidney, brain, gastrointestinal tissues, blood/immune cells,
and stem cells. In the later phase, post-translational modifications
and functional significance of Ch12-encoded proteins as well as their
associations with human diseases (i.e., immune diseases, metabolic
disorders, and cancers) will be defined. We have collaborated with
other chromosome teams, Human Kidney and Urine Proteome Project (HKUPP),
AOHUPO Membrane Proteomics Initiative, and other existing HUPO initiatives
in the Biology/Disease-Based Human Proteome Project (B/D-HPP) to delineate
functional roles and medical implications of Ch12-encoded proteins.
The data set to be obtained from this multicountry consortium will
be an important piece of the jigsaw puzzle to fulfill the missions
and goals of the C-HPP and the global Human Proteome Project (HPP)